EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , and other WHO priority pathogens, including Candida auris

Shyam Kumar Mishra iD, Muhammad Yasir, Rajesh Kuppusamy, Edgar H H Wong, Alex Hui, Kristian Sørensen, Jennifer S Lin, Håvard Jenssen, Annelise E Barron, Mark Willcox iD

Journal of Applied Microbiology · 2025

DOI: 10.1093/jambio/lxaf031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2025. Verfasst von Shyam Kumar Mishra und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Peptoids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC, NIH HHS, SENS Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The World Health Organization has identified ESKAPE bacteria and Candida auris as priority pathogens, emphasizing an urgent need for novel antimicrobials to combat them. This study aimed to explore the therapeutic potential of antimicrobial peptidomimetics, specifically peptoids with sequence-specific N-substituted glycines, against ESKAPEE pathogens, including metallo-β-lactamase (MBL) producers, as well as C. auris strains. Methods and results This study evaluated activity of the peptoids against the multidrug-resistant priority pathogens. The peptoid TM8 (with an N-decyl alkyl chain) demonstrated a geometric mean minimum inhibitory concentration (MIC) of 7.8 μg ml−1 against MBL-producing bacteria, and 5.5 μg ml−1 against C. auris. TM8 showed synergy with ciprofloxacin, enhancing its effectiveness 4-fold against NDM-1-producing Klebsiella pneumoniae. No antagonism was seen when TM8 was used with either conventional antibiotics or antifungals. Peptoids that had therapeutic indices below 3 were generally more hydrophobic, due to either alkyl chains or bromine. Scanning electron microscopy and live-dead staining assay on peptoid-treated C. auris confirmed morphological changes and killing activity, respectively. Furthermore, the peptoid could effectively inhibit biofilm formation by C. auris.

Conclusion

Peptoids demonstrated antibacterial activity against ESKAPEE, particularly against MBL-producing Gram-negative bacteria. Additionally, they exhibited antifungal and anti-biofilm activities against C. auris strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAcinetobacter baumanniiPseudomonas aeruginosaPeptoidsCandida aurisAnti-Bacterial AgentsMicrobial Sensitivity Testsbeta-LactamasesHumansBiofilmsDrug Resistance, Multiple, BacterialAntifungal Agents

Stichwörter der Autor:innen

Candida aurisESKAPEE pathogensbiofilmmetallo-β-lactamasemultidrug resistancepeptidomimeticsynergy

Substanzen

beta-LactamasesPeptoidsAnti-Bacterial AgentsAntifungal Agents

Autor:innen und Institutionen

  • School of Optometry and Vision Science, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
  • Department of Microbiology, Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Kathmandu 44600, Nepal.
  • School of Chemistry, Faculty of Science, University of New South Wales, Sydney, NSW 2052, Australia.
  • School of Chemical Engineering, Faculty of Engineering, University of New South Wales, Sydney, NSW 2052, Australia.
  • Department of Bioengineering, School of Medicine and School of Engineering, Stanford University, Stanford, CA 94305, USA.
  • Department of Science and Environment, Roskilde University, Roskilde 4000, Denmark.

ORCID-Profile: Shyam Kumar Mishra, Mark Willcox

Förderung

  • NHMRC
  • NIH HHS
  • SENS Research Foundation
  • Silicon Valley Community Foundation
  • Danish Council for Independent Research
  • NIH

Zitieren

APA

Mishra, S. K., Yasir, M., Kuppusamy, R., Wong, E. H. H., Hui, A., Sørensen, K., Lin, J. S., Jenssen, H., Barron, A. E., & Willcox, M. (2025). Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , and other WHO priority pathogens, including Candida auris. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxaf031

Vancouver

Mishra SK, Yasir M, Kuppusamy R, Wong EHH, Hui A, Sørensen K, et al. Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , and other WHO priority pathogens, including Candida auris. Journal of Applied Microbiology. 2025. doi:10.1093/jambio/lxaf031

BibTeX
@article{Mishra2025,
  author = {Mishra, Shyam Kumar and Yasir, Muhammad and Kuppusamy, Rajesh and Wong, Edgar H H and Hui, Alex and Sørensen, Kristian and Lin, Jennifer S and Jenssen, Håvard and Barron, Annelise E and Willcox, Mark},
  title = {Antimicrobial activity of peptoids against Metallo-β-lactamase-producing Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa , and other WHO priority pathogens, including Candida auris},
  journal = {Journal of Applied Microbiology},
  year = {2025},
  doi = {10.1093/jambio/lxaf031}
}
Kostenlos starten →